Amgen Spurns Breakup, Dusts Off $2B Buyback Plan

Amgen Inc. on Tuesday shrugged off investor pressure to split apart its operations as it gave a sunnier-than-expected forecast for next year's performance, saying also that it would resume a $2...

Already a subscriber? Click here to view full article